Trials / Unknown
UnknownNCT04980079
Primary Versus Deferred Ureteroscopy for Calculus Anuria in Children
Primary Versus Deferred Ureteroscopy for Management of Calculus Anuria in Children: A Prospective Randomized Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 1 Year – 12 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the role of both primary and deferred URS in the management of calculus anuria concerning the feasibility, clinical outcome, and cost-effectiveness in children in a comparative study
Detailed description
Thirty group B (30) patients will be admitted to do urinary drainage through the insertion of a JJ stent or percutaneous nephrostomy (PCN) at first , then a deferred URS will be done children will undergo primary URS( group A ) and in. Ureteral dilatation will be done when the stone size exceeds 10 mm to facilitate the extraction of the fragments. Ureteroscopic lithotripsy will be done using a 6.5:7.5 Fr semi-rigid ureteroscope and holmium laser. The ureteric stent will last for one week after lithotripsy. Postoperatively, the patients in both groups will monitored for post obstructive diuresis, fever, hematuria, and extent of renal function improvement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Primary ureterscopy URS | Ureteral dilatation will be done when the stone size exceeds 10 mm to facilitate the extraction of the fragments. Ureteroscopic lithotripsy will be done using a 6.5:7.5 Fr semi-rigid ureteroscope and holmium laser. The ureteric stent will last for one week after lithotripsy |
| PROCEDURE | deferred ureteroscopy URS | insertion of a double -J stent or percutaneous nephrostomy (PCN) at first , then a deferred ureteroscopy URS will be done . |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-11-15
- Completion
- 2021-12-30
- First posted
- 2021-07-28
- Last updated
- 2021-07-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04980079. Inclusion in this directory is not an endorsement.